Table 4.

Immunophenotipic analyses (percentages of cells) in 3 groups of older children (mean age = 7 years)

MarkerSR (n = 41)UC (n = 15)HIV+ (n = 25)Statistical significance (P value)
SR vs UCSR vs HIV+UC vs HIV+
CD4 38.4 ± 6.8 40.4 ± 4.6 28.2 ± 9.9 ns .0004 < .0001 
CD8 24.2 ± 5.3 25.6 ± 3.7 42.9 ± 11.1 ns < .0001 .0001 
CD4/CD8 ratio 1.7 ± 0.7 1.6 ± 0.3 0.8 ± 0.5 ns < .0001 < .0001 
CD4/RA/62 62.9 ± 9.8 71.8 ± 8.6 57.9 ± 9.6 .03 ns .001 
CD4/RO 37.1 ± 10.1 29.1 ± 8.6 42.3 ± 14.2 .001 ns .001 
CD8/RA/LFAlow 40.7 ± 8.5 48.9 ± 4.2 22.7 ± 4.1 ns .0001 < .0001 
CD8/RA/LFAhigh 25.3 ± 2.2 26.6 ± 4.7 28.2 ± 3.5 ns ns ns 
CD8/38dim 34 ± 13.7 48.7 ± 6.2 47.5 ± 13.6 .004 .003 ns 
CD8/38bright 15.5 ± 5.6 5.6 ± 1.4 25.4 ± 8.1 .01 .009 .001 
CD3 DN 9.3 ± 2.2 6.5 ± 2.3 11.9 ± 4.9 .02 ns .002 
CD3 DN/44 8.4 ± 2.7 5.1 ± 3.7 11.5 ± 5.1 .001 ns .001 
MarkerSR (n = 41)UC (n = 15)HIV+ (n = 25)Statistical significance (P value)
SR vs UCSR vs HIV+UC vs HIV+
CD4 38.4 ± 6.8 40.4 ± 4.6 28.2 ± 9.9 ns .0004 < .0001 
CD8 24.2 ± 5.3 25.6 ± 3.7 42.9 ± 11.1 ns < .0001 .0001 
CD4/CD8 ratio 1.7 ± 0.7 1.6 ± 0.3 0.8 ± 0.5 ns < .0001 < .0001 
CD4/RA/62 62.9 ± 9.8 71.8 ± 8.6 57.9 ± 9.6 .03 ns .001 
CD4/RO 37.1 ± 10.1 29.1 ± 8.6 42.3 ± 14.2 .001 ns .001 
CD8/RA/LFAlow 40.7 ± 8.5 48.9 ± 4.2 22.7 ± 4.1 ns .0001 < .0001 
CD8/RA/LFAhigh 25.3 ± 2.2 26.6 ± 4.7 28.2 ± 3.5 ns ns ns 
CD8/38dim 34 ± 13.7 48.7 ± 6.2 47.5 ± 13.6 .004 .003 ns 
CD8/38bright 15.5 ± 5.6 5.6 ± 1.4 25.4 ± 8.1 .01 .009 .001 
CD3 DN 9.3 ± 2.2 6.5 ± 2.3 11.9 ± 4.9 .02 ns .002 
CD3 DN/44 8.4 ± 2.7 5.1 ± 3.7 11.5 ± 5.1 .001 ns .001 

SR = healthy HIV-uninfected children of HIV-infected mothers (seroreverters); UC = healthy children of HIV-negative women (uninfected controls); HIV+ = HIV-infected children; ns = statistically not significant; DN = double negatives; LFA = leukocyte function-associated antigen.

Mean values ± standard deviations are shown.

Close Modal

or Create an Account

Close Modal
Close Modal